As depicted in Figure 4a and b, no change was either observed in PEA3, which specifically reverses the in vitro transformed phenotype of Her2+ breast cancer cells by reducing Her2 oncogene promoter activity (Xing et al., 2000). Here, ERBB2 is linked to breast carcinoma.